NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.


What is Axicabtagene Ciloleucel approved to treat?

  1. Breast cancer

  2. Large B-cell lymphoma

  3. Colon cancer

  4. Hepatocellular carcinoma

The correct answer is: Large B-cell lymphoma

Axicabtagene Ciloleucel is a type of chimeric antigen receptor (CAR) T-cell therapy that uses the patient's own immune cells to target and destroy cancer cells. It has been specifically approved by the FDA for the treatment of adults with relapsed or refractory large B-cell lymphoma, which is a type of aggressive non-Hodgkin's lymphoma. Therefore, options A, C, and D are incorrect as they do not relate to large B-cell lymphoma. It is important to note that this treatment may not be suitable for all patients and should be discussed with a doctor.